Basisdiagnostik Klein

Essential metabolic screening with seven core biomarkers covering blood sugar control, lipid levels, kidney function, and liver enzymes. At under €44 all-inclusive, a practical entry-level health check for adults without specific risk factors.

The Basisdiagnostik Klein profile combines the most clinically informative single markers from each major organ system into a compact screen. Complete blood count provides an overview of red cell, white cell, and platelet populations — detecting anaemia, infection signals, and clotting abnormalities in a single automated analysis. HbA1c reflects average blood glucose over the preceding eight to twelve weeks, making it a more reliable diabetes indicator than a single fasting glucose measurement. The diagnostic threshold for type 2 diabetes is 6.5% (48 mmol/mol), while 5.7-6.4% identifies the pre-diabetic range where lifestyle intervention is most effective. Germany has an estimated 2 million undiagnosed cases of type 2 diabetes, making routine HbA1c screening particularly valuable. Total cholesterol and triglycerides provide a first-pass cardiovascular risk assessment. While a full lipid panel with HDL and LDL fractionation offers more detail, elevated total cholesterol or triglycerides above 150 mg/dL are sufficient to flag individuals who need further evaluation. Creatinine with calculated eGFR screens for chronic kidney disease, which is asymptomatic in its early stages and affects roughly 10% of the adult population. ASAT and ALAT (also known as AST and ALT) screen for hepatocellular damage — ALAT being more liver-specific, while ASAT elevation can also originate from cardiac or skeletal muscle. This panel is well suited as a low-cost annual screen for healthy adults under 40. Those with family history of cardiovascular disease, diabetes, or metabolic syndrome should consider the Basisdiagnostik Gross for broader coverage.